Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Leukemia, Published online: 14 November 2019; doi:10.1038/s41375-019-0629-zHypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Source: Leukemia - November 13, 2019 Category: Hematology Authors: Julian Baumeister Nicolas Chatain Annika Hubrich Tiago Mai é Ivan G. Costa Bernd Denecke Lijuan Han Caroline K üstermann Stephanie Sontag Kristin Ser é Klaus Strathmann Martin Zenke Andreas Schuppert Tim H. Br ümmendorf Kamil R. Kranc Steffen Koschmie Source Type: research